Financials

  • Market Capitalization 177.58 M
  • Employee 142
  • Founded 2007
  • CEO Seth Lederman
  • Website www.tonixpharma.com
  • Headquarter Nevada, United States
  • FIGI BBG000LG8XM5
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.07
Price to sales ratio
10.14

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3690
KRRO
Korro Bio, Inc. - Common Stock
13.19 USD-2.30%-10.70%+11.50%-66.09%190.23 M USD
3698
EQ
Equillium, Inc. - Common Stock
2.90 USD+0.69%+1.75%+0.35%+752.94%183.36 M USD
3700
PRQR
ProQR Therapeutics N.V. - Ordinary Shares
1.74 USD+2.35%+9.43%+19.18%-29.84%183.33 M USD
3706
CRBU
Caribou Biosciences, Inc. - Common Stock
1.77 USD-1.67%-3.28%+8.59%+2.91%175.55 M USD

Frequently asked questions about Tonix Pharmaceuticals Holding Corp. - Common Stock

What is the Tonix Pharmaceuticals Holding Corp. - Common Stock stock price today?

The current price of Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP) is 11.14. Over the past 24 hours, the stock has changed by -4.87%. Follow the TNXP chart for real-time price dynamics.

What is the stock ticker of Tonix Pharmaceuticals Holding Corp. - Common Stock?

Tonix Pharmaceuticals Holding Corp. - Common Stock trades under the ticker TNXP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Tonix Pharmaceuticals Holding Corp. - Common Stock stock going up?

TNXP has changed by -10.02% over the last week, -4.95% over the last month, and -25.78% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Tonix Pharmaceuticals Holding Corp. - Common Stock net income for the last quarter?

Tonix Pharmaceuticals Holding Corp. - Common Stock reported net income of -40.19 M for the last quarter. The previous quarter showed -46.91 M, which means net income changed by +14.32%.

How many employees does Tonix Pharmaceuticals Holding Corp. - Common Stock have?

As of the latest available data, Tonix Pharmaceuticals Holding Corp. - Common Stock has 142 employees. Workforce size can provide additional context about the company's scale and operations.

What is Tonix Pharmaceuticals Holding Corp. - Common Stock EBITDA?

Tonix Pharmaceuticals Holding Corp. - Common Stock EBITDA is -40.98 M, and its EBITDA margin is -595.84%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Tonix Pharmaceuticals Holding Corp. - Common Stock stock?

You can buy Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Tonix Pharmaceuticals Holding Corp. - Common Stock stock?

Investing in Tonix Pharmaceuticals Holding Corp. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TNXP chart and related analysis on metatrader.com as part of your research.

Tonix Pharmaceuticals Holding Corp. - Common Stock

Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.

News